{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:08:40Z","timestamp":1776276520703,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11096-019-00859-7","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T05:14:08Z","timestamp":1559798048000},"page":"864-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0055-6415","authenticated-orcid":false,"given":"Jakub","family":"Wro\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Fiedor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"G\u0142uszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"859_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, Jones GT, Macdonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology (United Kingdom). 2014;53:650\u20137.","journal-title":"Rheumatology (United Kingdom)"},{"key":"859_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D Van Der Heijde","year":"2017","unstructured":"Van Der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van Den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391.","journal-title":"Ann Rheum Dis"},{"key":"859_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010952.pub2","author":"FP Kroon","year":"2015","unstructured":"Kroon FP, van der Burg LR, Ramiro S, Landew\u00e9 RB, Buchbinder R, Falzon L, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non- radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010952.pub2\n                    \n                  .","journal-title":"Cochrane Database Syst Rev."},{"key":"859_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468.pub2","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MMS, Tanjong Ghogomu E, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005468.pub2\n                    \n                  .","journal-title":"Cochrane Database Syst Rev."},{"key":"859_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"C Molnar","year":"2018","unstructured":"Molnar C, Scherer A, Baraliakos X, De Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: Results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63\u20139.","journal-title":"Ann Rheum Dis"},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/rheumatology\/kew033","volume":"55","author":"V Navarro-Comp\u00e1n","year":"2016","unstructured":"Navarro-Comp\u00e1n V, Plasencia-Rodr\u00edguez C, de Miguel E, Balsa A, Mart\u00edn-Mola E, Seoane-Mato D, et al. Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review. Rheumatology (United Kingdom). 2016;55:1188\u201394.","journal-title":"Rheumatology (United Kingdom)"},{"key":"859_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jcph.1348","volume":"59","author":"J Wro\u0144ski","year":"2019","unstructured":"Wro\u0144ski J, Fiedor P. The safety profile of tumor necrosis factor inhibitors in ankylosing spondylitis: are TNF inhibitors safer than we thought? J Clin Pharmacol. 2019;59:445\u201362.","journal-title":"J Clin Pharmacol"},{"key":"859_CR8","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 2017. \n                    https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf\n                    \n                  . Accessed 9 March 2018."},{"key":"859_CR9","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00296-013-2772-6","volume":"33","author":"MAD\u00c1 Machado","year":"2013","unstructured":"Machado MAD\u00c1, Barbosa MM, Almeida AM, De Ara\u00fajo VE, Kakehasi AM, Andrade EIG, et al. Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis. Rheumatol Int. 2013;33:2199\u2013213.","journal-title":"Rheumatol Int"},{"key":"859_CR10","doi-asserted-by":"publisher","first-page":"32768","DOI":"10.1038\/srep32768","volume":"6","author":"W Liu","year":"2016","unstructured":"Liu W, Wu Y, Zhang L, Liu X, Xue Bin, Liu Bin, et al. Efficacy and safety of TNF-\u03b1 inhibitors for active ankylosing spondylitis patients: multiple treatment comparisons in a network meta-analysis. Sci Rep. 2016;6:32768.","journal-title":"Sci Rep"},{"key":"859_CR11","doi-asserted-by":"publisher","first-page":"e7145","DOI":"10.1097\/MD.0000000000007145","volume":"96","author":"Z Ma","year":"2017","unstructured":"Ma Z, Liu X, Xu X, Jiang J, Zhou J, Wang J, et al. Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: a meta-analysis. Medicine (Baltimore). 2017;96:e7145.","journal-title":"Medicine (Baltimore)"},{"key":"859_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-017-8623-6","volume":"54","author":"L Hou","year":"2018","unstructured":"Hou L, Jiang G, Chen Y, Yang XM, Meng L, Xue M, et al. The comparative safety of TNF inhibitors in ankylosing spondylitis\u2014a meta-analysis update of 14 randomized controlled trials. Clin Rev Allergy Immunol. 2018;54:234\u201343.","journal-title":"Clin Rev Allergy Immunol"},{"key":"859_CR13","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3892\/etm.2017.5003","volume":"14","author":"Z Xu","year":"2017","unstructured":"Xu Z, Xu P, Fan W, Yang G, Wang J, Cheng Q, et al. Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials. Exp Ther Med. 2017;14:3491\u2013500.","journal-title":"Exp Ther Med"},{"key":"859_CR14","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1136\/ard.2008.098822","volume":"69","author":"A Fouque-Aubert","year":"2010","unstructured":"Fouque-Aubert A, Jette-Paulin L, Combescure C, Basch A, Tebib J, Gossec L. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. Ann Rheum Dis. 2010;69:1756\u201361.","journal-title":"Ann Rheum Dis"},{"key":"859_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14740338.2016.1238458","volume":"15","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Minozzi S, Lytras T, Gonz\u00e1lez-Lorenzo M, Pecoraro V, Colombo S, et al. Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin Drug Saf. 2016;15:35\u201354.","journal-title":"Expert Opin Drug Saf"},{"key":"859_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/path.4187","volume":"230","author":"JP Waters","year":"2013","unstructured":"Waters JP, Pober JS, Bradley JR. Tumour necrosis factor in infectious disease. J Pathol. 2013;230:132\u201347.","journal-title":"J Pathol"},{"key":"859_CR17","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA. 2006;295:2275.","journal-title":"JAMA"},{"key":"859_CR18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.amjmed.2014.06.012","volume":"127","author":"TL Michaud","year":"2014","unstructured":"Michaud TL, Rho YH, Shamliyan T, Kuntz KM, Choi HK. The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials. Am J Med. 2014;127:1208\u201332.","journal-title":"Am J Med"},{"key":"859_CR19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3899\/jrheum.091107","volume":"37","author":"S Bernatsky","year":"2010","unstructured":"Bernatsky S, Habel Y, Rahme E. Observational studies of infections in rheumatoid arthritis: a metaanalysis of tumor necrosis factor antagonists. J Rheumatol. 2010;37:928\u201331.","journal-title":"J Rheumatol"},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jbspin.2016.02.028","volume":"84","author":"Divonne M de La Forest","year":"2017","unstructured":"de La Forest Divonne M, Gottenberg JE, Salliot C. Safety of biologic DMARDs in RA patients in real life: a systematic literature review and meta-analyses of biologic registers. Jt Bone Spine. 2017;84:133\u201340.","journal-title":"Jt Bone Spine"},{"key":"859_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/rheumatology\/keu255","volume":"54","author":"D Wallis","year":"2015","unstructured":"Wallis D, Thavaneswaran A, Haroon N, Ayearst R, Inman RD. Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort. Rheumatology. 2015;54:152\u20136.","journal-title":"Rheumatology"},{"key":"859_CR22","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287\u201393.","journal-title":"Arthritis Rheum"},{"key":"859_CR23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s10067-013-2387-z","volume":"33","author":"HW Kim","year":"2014","unstructured":"Kim HW, Park JK, Yang JA, Yoon YI, Lee EY, Song YW, et al. Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area. Clin Rheumatol. 2014;33:1307\u201312.","journal-title":"Clin Rheumatol"},{"key":"859_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/14397595.2017.1325034","volume":"28","author":"D-H Lim","year":"2018","unstructured":"Lim D-H, Kim Y-J, Kim SO, Hong S, Lee C-K, Yoo B, et al. The risk of herpes zoster in patients with ankylosing spondylitis: analysis of the Korean National Health Insurance Service\u2014sample cohort database. Mod Rheumatol. 2018;28:168\u201373.","journal-title":"Mod Rheumatol"},{"key":"859_CR25","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3899\/jrheum.150057","volume":"42","author":"J-W Ai","year":"2015","unstructured":"Ai J-W, Zhang S, Ruan Q-L, Yu Y-Q, Zhang B-Y, Liu Q-H, et al. The risk of tuberculosis in patients with rheumatoid arthritis treated with tumor necrosis factor- antagonist: a metaanalysis of both randomized controlled trials and registry\/cohort studies. J Rheumatol. 2015;42:2229\u201337.","journal-title":"J Rheumatol"},{"key":"859_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/gut.52.2.260","volume":"52","author":"I Etienney","year":"2003","unstructured":"Etienney I, Beaugerie L, Viboud C, Flahault A. Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut. 2003;52:260\u20133.","journal-title":"Gut"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00859-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00859-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00859-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:31:26Z","timestamp":1591313486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00859-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00859-7","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}